Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion

COVID-19 caused by SARS-CoV-2 has posed a significant threat to global public health since its outbreak in late 2019. Although there are a few drugs approved for clinical treatment to combat SARS-CoV-2 infection currently, the severity of the ongoing global pandemic still urges the efforts to discov...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhe-Rui, Zhang, Ya-Nan, Zhang, Hong-Qing, Zhang, Qiu-Yan, Li, Na, Li, Qi, Deng, Cheng-Lin, Zhang, Bo, Li, Xiao-Dan, Ye, Han-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071123/
https://www.ncbi.nlm.nih.gov/pubmed/35468133
http://dx.doi.org/10.1371/journal.pntd.0010363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071123/
https://www.ncbi.nlm.nih.gov/pubmed/35468133
http://dx.doi.org/10.1371/journal.pntd.0010363

Ejemplares similares